SAFETY AND IMMUNOGENICITY OF LIVE ORAL CHOLERA VACCINE CANDIDATE CVD 110, A DELTA-CTXA DELTA-ZOT DELTA-ACE DERIVATIVE OF EL-TOR OGAWA VIBRIO-CHOLERAE

被引:87
作者
TACKET, CO [1 ]
LOSONSKY, G [1 ]
NATARO, JP [1 ]
CRYZ, SJ [1 ]
EDELMAN, R [1 ]
FASANO, A [1 ]
MICHALSKI, J [1 ]
KAPER, JB [1 ]
LEVINE, MM [1 ]
机构
[1] SWISS SERUM & VACCINE INST,BERN,SWITZERLAND
关键词
D O I
10.1093/infdis/168.6.1536
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The current pandemic of cholera is caused primarily by Vibrio cholerae 01 of the El Tor biotype. Live attenuated classical biotype V. cholerae vaccine strains prevent severe and moderate cholera due to either biotype in challenged volunteers but may provide less protection against mild cholera due to El Tor organisms. CVD 110, a new ctxA-deleted vaccine strain derived from an El Tor Ogawa parent, lacks zona occludens toxin (Zot), accessory cholera enterotoxin (Ace), and hemolysin/enterotoxin. Ten healthy adult volunteers were given 10(8) cfu of CVD 110 with buffer; 7 developed diarrhea (mean stool volume, 861 mL). Vaccine organisms were shed in stool by all vaccinees and were recovered from duodenal fluid in three-quarters of vaccinees. After vaccination, the geometric mean peak reciprocal vibriocidal titer among vaccinees was 17,829. CVD 110 is a powerful immunogen but insufficiently attenuated despite the absence of known potential enterotoxins of V. cholerae. Another unrecognized toxin or colonization alone may be responsible for diarrhea after ingestion of this strain.
引用
收藏
页码:1536 / 1540
页数:5
相关论文
共 17 条
[1]   VIBRIO-CHOLERAE PRODUCES A 2ND ENTEROTOXIN, WHICH AFFECTS INTESTINAL TIGHT JUNCTIONS [J].
FASANO, A ;
BAUDRY, B ;
PUMPLIN, DW ;
WASSERMAN, SS ;
TALL, BD ;
KETLEY, JM ;
KAPER, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5242-5246
[2]   PATHOGENESIS OF SHIGELLA DIARRHEA .16. SELECTIVE TARGETTING OF SHIGA TOXIN TO VILLUS CELLS OF RABBIT JEJUNUM EXPLAINS THE EFFECT OF THE TOXIN ON INTESTINAL ELECTROLYTE TRANSPORT [J].
KANDEL, G ;
DONOHUEROLFE, A ;
DONOWITZ, M ;
KEUSCH, GT .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1509-1517
[3]  
LEVINE M M, 1988, Lancet, V2, P467
[4]   THE PATHOGENICITY OF NON-ENTEROTOXIGENIC VIBRIO-CHOLERAE SEROGROUP O1 BIOTYPE EL-TOR ISOLATED FROM SEWAGE WATER IN BRAZIL [J].
LEVINE, MM ;
BLACK, RE ;
CLEMENTS, ML ;
CISNEROS, L ;
SAAH, A ;
NALIN, DR ;
GILL, DM ;
CRAIG, JP ;
YOUNG, CR ;
RISTAINO, P .
JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (03) :296-299
[5]   LIVE ORAL VACCINES AGAINST CHOLERA - AN UPDATE [J].
LEVINE, MM ;
KAPER, JB .
VACCINE, 1993, 11 (02) :207-212
[6]   VOLUNTEER STUDIES OF DELETION MUTANTS OF VIBRIO-CHOLERAE O1 PREPARED BY RECOMBINANT TECHNIQUES [J].
LEVINE, MM ;
KAPER, JB ;
HERRINGTON, D ;
LOSONSKY, G ;
MORRIS, JG ;
CLEMENTS, ML ;
BLACK, RE ;
TALL, B ;
HALL, R .
INFECTION AND IMMUNITY, 1988, 56 (01) :161-167
[7]  
LEVINE MM, 1986, MOL BIOL MICROBIAL P
[8]   SECONDARY VIBRIO-CHOLERAE-SPECIFIC CELLULAR ANTIBODY-RESPONSES FOLLOWING WILD-TYPE HOMOLOGOUS CHALLENGE IN PEOPLE VACCINATED WITH CVD 103-HGR LIVE ORAL CHOLERA VACCINE - CHANGES WITH TIME AND LACK OF CORRELATION WITH PROTECTION [J].
LOSONSKY, GA ;
TACKET, CO ;
WASSERMAN, SS ;
KAPER, JB ;
LEVINE, MM .
INFECTION AND IMMUNITY, 1993, 61 (02) :729-733
[9]  
MADDEN JM, 1984, LANCET, V1, P1217
[10]  
OBRIEN AD, 1984, LANCET, V1, P77